SCHEMBL4087293

SCHEMBL4087293

COC(=O)C(N)Cc1ccc(Oc2ccc(N)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.50
ALDH1A1 P00352 2/20 0.46
LTA4H P09960 1/20 0.44
PARP10 Q53GL7 1/20 0.44
CYP3A4 P08684 1/20 0.42
TSHR P16473 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
LDHA P00338 1/20 0.41
TPH1 P17752 1/20 0.41
ACACB O00763 1/20 0.41
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41
TEAD4 Q15561 1/20 0.41
PTPN1 P18031 1/20 0.40
DPP4 P27487 2/20 0.40
DPP8 Q6V1X1 2/20 0.40
DPP9 Q86TI2 2/20 0.40
DPP7 Q9UHL4 2/20 0.40
SLC6A4 P31645 1/20 0.40
FAP Q12884 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27477965 0.92 ALDH1A1 (0.51) PTGS2ALDH1A1LTA4HESR1ESR2
SCHEMBL1108340 0.92 ALDH1A1 (0.51) PTGS2ALDH1A1LTA4HESR1ESR2
SCHEMBL5916451 0.92 ALDH1A1 (0.51) PTGS2ALDH1A1LTA4HESR1ESR2
Hydrochloric Acid SCHEMBL7385556 0.91 ALDH1A1 (0.53) PTGS2ALDH1A1LTA4HESR1ESR2
Hydrochloric Acid SCHEMBL7387839 0.91 ALDH1A1 (0.53) PTGS2ALDH1A1LTA4HESR1ESR2
Hydrochloric Acid SCHEMBL3871196 0.91 ALDH1A1 (0.53) PTGS2ALDH1A1LTA4HESR1ESR2
SCHEMBL7273637 0.88 ESR1 (0.55) PTGS2ALDH1A1LTA4HESR1ESR2
SCHEMBL29183302 0.88 ACACB (0.53) PTGS2LTA4HTPH1ACACBPPARG
SCHEMBL2292317 0.88 ACACB (0.53) PTGS2LTA4HTPH1ACACBPPARG
SCHEMBL8255298 0.88 ACACB (0.53) PTGS2LTA4HTPH1ACACBPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090082408-A1 NOVEL HETEROCYCLIC DERIVATIVES ORCHID RESEARCH LABORATORIES LIMITED (IN) 2009-03-26 US disclosed
WO-2008029217-A2 DIPEPTIDYL PEPTIDASE IV INHIBITORS ORCHID RESEARCH LABORATORIES LIMITED (IN) 2008-03-13 WO disclosed
EP-1883629-A2 NOVEL HETEROCYCLIC DERIVATIVES Orchid Research Laboratories Limited (IN) 2008-02-06 EP disclosed
WO-2006123229-A2 NOVEL HETEROCYCLIC DERIVATIVES ORCHID RESEARCH LABORATORIES LIMITED (IN) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090082408-A1 NOVEL HETEROCYCLIC DERIVATIVES CYP3A5, CYP3A7, UGT2B7 PTGS2 954/4885ALDH1A1 281/4885LTA4H 1499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.